DK1214056T3 - Topiske suspensionsformuleringer indeholdende ciprofloxacin og dexamethason - Google Patents

Topiske suspensionsformuleringer indeholdende ciprofloxacin og dexamethason

Info

Publication number
DK1214056T3
DK1214056T3 DK00959213T DK00959213T DK1214056T3 DK 1214056 T3 DK1214056 T3 DK 1214056T3 DK 00959213 T DK00959213 T DK 00959213T DK 00959213 T DK00959213 T DK 00959213T DK 1214056 T3 DK1214056 T3 DK 1214056T3
Authority
DK
Denmark
Prior art keywords
dexamethasone
formulations containing
suspension formulations
topical suspension
containing ciprofloxacin
Prior art date
Application number
DK00959213T
Other languages
Danish (da)
English (en)
Inventor
Onkar N Singh
Haresh G Bhagat
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22557406&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1214056(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Inc filed Critical Alcon Inc
Application granted granted Critical
Publication of DK1214056T3 publication Critical patent/DK1214056T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK00959213T 1999-09-24 2000-08-10 Topiske suspensionsformuleringer indeholdende ciprofloxacin og dexamethason DK1214056T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15594299P 1999-09-24 1999-09-24
PCT/US2000/021961 WO2001022936A1 (en) 1999-09-24 2000-08-10 Topical suspension formulations containing ciprofloxacin and dexamethasone

Publications (1)

Publication Number Publication Date
DK1214056T3 true DK1214056T3 (da) 2004-02-09

Family

ID=22557406

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00959213T DK1214056T3 (da) 1999-09-24 2000-08-10 Topiske suspensionsformuleringer indeholdende ciprofloxacin og dexamethason

Country Status (22)

Country Link
US (2) US6284804B1 (tr)
EP (1) EP1214056B1 (tr)
JP (2) JP2003510263A (tr)
KR (1) KR100722502B1 (tr)
CN (1) CN1158994C (tr)
AR (1) AR025661A1 (tr)
AT (1) ATE252887T1 (tr)
AU (1) AU776609B2 (tr)
BR (1) BR0014203A (tr)
CA (1) CA2379605C (tr)
DE (1) DE60006262T2 (tr)
DK (1) DK1214056T3 (tr)
ES (1) ES2207549T3 (tr)
HK (1) HK1045653B (tr)
MX (1) MXPA02003130A (tr)
PL (1) PL201130B1 (tr)
PT (1) PT1214056E (tr)
SA (1) SA00210418B1 (tr)
TR (1) TR200200737T2 (tr)
TW (1) TWI228423B (tr)
WO (1) WO2001022936A1 (tr)
ZA (1) ZA200201904B (tr)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE252887T1 (de) * 1999-09-24 2003-11-15 Alcon Inc Topische suspensionsformulierungen enthaltend ciprofloxacin und dexamethason
MXPA03004241A (es) * 2000-11-15 2004-12-03 Chandavarkar Mohan A Preparaciones farmaceuticas que comprenden corticosteroides y agentes antiinfecciosos.
NZ530845A (en) * 2001-07-06 2006-03-31 Sucampo Ag Composition for topical administration
MXPA04002576A (es) * 2001-09-21 2004-06-18 Alcon Inc Metodo para tratar infecciones del oido medio.
US20090215735A1 (en) * 2002-02-25 2009-08-27 Alcon, Inc. Topical solution formulations containing a corticosteroid and a cyclodextrin
JP4662714B2 (ja) * 2002-03-01 2011-03-30 セルテック アール アンド ディー インコーポレイテッド 骨密度を増減させる方法
AU2003280960A1 (en) * 2002-07-15 2004-02-02 Alcon, Inc. Pharmaceutical compositions for otic use
US20040101506A1 (en) * 2002-11-25 2004-05-27 Fust Charles A. Composition for the prevention and treatment of inflammation of the ear
US7220431B2 (en) 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
UY28126A1 (es) * 2002-12-24 2004-06-30 Alcon Inc Uso de glucocorticoides selectivos para la superficie ocular en el tratamiento de la sequedad ocular
MXPA05008913A (es) * 2003-02-21 2005-10-05 Sun Pharmaceutical Ind Ltd Formulacion oftalmica estable que contiene antibiotico y corticoesteroide.
US20050085446A1 (en) * 2003-04-14 2005-04-21 Babu M.K. M. Fluoroquinolone formulations and methods of making and using the same
US20040202687A1 (en) * 2003-04-14 2004-10-14 Babu M.K. Manoj Ciprofloxacin formulations and methods of making and using the same
EP1627637A1 (en) * 2003-05-23 2006-02-22 Santen Pharmaceutical Co., Ltd. Ophthalmic solution containing quinolone antimicrobial compound
US8940321B2 (en) * 2003-12-12 2015-01-27 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
WO2005055921A2 (en) 2003-12-12 2005-06-23 Eran Eilat Compositions for treatment of ear disorders and methods of use thereof
ES2245611B1 (es) * 2004-06-29 2007-03-16 Laboratorio Reig Jofre, S.A. Composicion farmaceutica para uso ototopico.
US20060019987A1 (en) * 2004-07-23 2006-01-26 Fust Charles A Methods and compositions for inhibiting, destroying, and/or inactivating viruses
DE102006010643A1 (de) * 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
US7993675B2 (en) 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US7959943B2 (en) * 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US20070264296A1 (en) * 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US7976873B2 (en) * 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
WO2008035246A2 (en) 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
US8088095B2 (en) 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
CN101317847B (zh) * 2007-06-06 2010-10-13 深圳市瑞谷医药技术有限公司 一种眼用或耳鼻用药物组合物及其用途
US8271101B2 (en) * 2007-08-29 2012-09-18 Advanced Bionics Modular drug delivery system for minimizing trauma during and after insertion of a cochlear lead
JP4696251B2 (ja) * 2007-12-28 2011-06-08 防衛省技術研究本部長 多剤耐性緑膿菌の単離方法並びに多剤耐性緑膿菌選択培地の作成方法
JP2011512903A (ja) 2008-02-25 2011-04-28 アイゲート ファーマ エスエーエス イオントフォレシスを介した眼組織への治療薬の向上した送達
MY161021A (en) * 2008-05-14 2017-03-31 Otonomy Inc Controlled release corticosteroid and methods for the treatment of otic disorders
RU2513142C2 (ru) 2008-06-12 2014-04-20 Медтроник Ксомед Инк. Способ лечения хронических ран
WO2010004594A1 (en) * 2008-07-08 2010-01-14 S.I.F.I. Societa' Industria Farmaceutica Italiana S.P.A. Ophthalmic compositions for treating pathologies of the posterior segment of the eye
US20100016450A1 (en) * 2008-07-21 2010-01-21 Otonomy, Inc. Controlled release delivery devices for the treatment of otic disorders
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
EP2346324A4 (en) 2008-10-06 2012-10-10 Microbial Defense Systems Llc ANTIMICROBIAL COMPOSITION AND METHODS OF MAKING AND USING
TW201023912A (en) 2008-12-05 2010-07-01 Alcon Res Ltd Pharmaceutical suspension
WO2010101971A1 (en) * 2009-03-03 2010-09-10 Alcon Research, Ltd. Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye
WO2010101989A1 (en) * 2009-03-03 2010-09-10 Alcon Research, Ltd. PHARMACEUTICAL COMPOSITION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
EP3508197A1 (en) * 2009-10-21 2019-07-10 Otonomy, Inc. Modulation of gel temperature of poloxamer-containing formulations
PL2366408T3 (pl) 2010-03-01 2013-01-31 Salvat Lab Sa Klarowne roztwory wodne acetonidu fluocinolonu do leczenia zapalenia uszu
US8916171B2 (en) 2010-04-27 2014-12-23 Topical Sinus Therapeutics, Inc. Topical delivery of viscous medications for the treatment of diseases associated with chronic sinusitis
AU2012253476B2 (en) 2011-05-10 2015-09-24 Next Science IP Holdings Pty Ltd Antimicrobial solid and methods of making and using same
BR112014013564A8 (pt) * 2011-12-09 2017-06-13 Lupin Ltd composição farmacêutica tópica destinada à aplicação ao olho, ouvido ou nariz
CN103565816A (zh) * 2012-07-25 2014-02-12 天津金耀集团有限公司 妥布霉素地塞米松滴眼液
WO2014102788A1 (en) 2012-12-26 2014-07-03 Otic Pharma Ltd. Foamable otic pharmaceutical compositions
US20150164882A1 (en) 2013-07-22 2015-06-18 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
US20160279055A1 (en) 2013-07-22 2016-09-29 Imprimis Pharmaceuticals, Inc. Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof
MX2016002408A (es) 2013-08-27 2016-10-28 Otonomy Inc Metodos para el tratamiento de trastornos oticos pediatricos.
US20150119371A1 (en) * 2013-10-30 2015-04-30 Micro Labs Limited Topical pharmaceutical compositions of antibiotics and steroidal anti inflammatory agents
JP6297180B2 (ja) 2014-07-03 2018-03-20 オトノミ—，インク． シプロフロキサシン組成物の滅菌
US9393243B1 (en) * 2015-07-14 2016-07-19 Nilesh Parikh Topical Ciprofloxacin compositions
KR20190109604A (ko) * 2016-05-06 2019-09-25 해로우 헬스 인코포레이티드 약학적 안과용 조성물 및 그의 제조 방법
KR102395835B1 (ko) * 2016-08-24 2022-05-10 키에시 파르마슈티시 엣스. 피. 에이. 재구성된 폐 계면활성제 조성물을 포함하는 안정한 약제학적 제제
US11040004B2 (en) 2016-09-16 2021-06-22 Otonomy, Inc. Otic gel formulations for treating otitis externa
CN107970244B (zh) * 2016-10-21 2020-07-14 武汉武药科技有限公司 一种含有环丙沙星和地塞米松的组合物及其制备方法
CN108403700A (zh) * 2018-06-12 2018-08-17 新疆生产建设兵团第师畜牧兽医工作站 一种牛呼吸道疾病治疗用复合注射液
JP6994061B2 (ja) * 2019-02-15 2022-01-14 ノバルティス アーゲー ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの製剤
CN113797164B (zh) * 2020-06-17 2023-07-14 成都瑞沐生物医药科技有限公司 一种眼用制剂的载体或辅料及其制备方法和应用
CN113144207A (zh) * 2021-02-07 2021-07-23 山西利普达医药科技有限公司 一种包括聚季铵盐-1的组合物及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3134718A (en) 1963-12-12 1964-05-26 Schering Corp Pregna-1,4-dienes and compositions containing same
US4670444B1 (en) 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
US5223493A (en) 1984-12-28 1993-06-29 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
US4686214A (en) 1985-10-30 1987-08-11 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
DE3704907A1 (de) 1987-02-17 1988-08-25 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren in kombination mit kortikosteroiden
GB8805268D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments
WO1990001933A1 (en) * 1988-08-26 1990-03-08 Alcon Laboratories, Inc. Combination of quinolone antibiotics and steroids for topical ophthalmic use
DE69224071T2 (de) 1991-09-17 1998-05-07 Alcon Lab Inc Chinolan-antibiotika und polystyrolsulfonat enthaltende zusammensetzungen
ES2065846B1 (es) * 1993-04-20 1995-10-01 Cusi Lab Formulacion farmaceutica a base de un agente antiinflamatorio esteroidico o no esteroidico y un antibiotico pertenciente al grupo de los inhibidores de la adn girasa para su utilizacion topica oftalmica.
US5540930A (en) 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
US5420120A (en) 1993-12-17 1995-05-30 Alcon Laboratories, Inc. Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
JP3781792B2 (ja) * 1993-12-27 2006-05-31 千寿製薬株式会社 ジフルプレドナート含有点眼用懸濁液剤
ES2078175B1 (es) 1993-12-31 1996-10-16 Cusi Lab Formulacion farmaceutica conteniendo clobetasona y tobramicina y sus aplicaciones.
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
US5843930A (en) 1995-06-06 1998-12-01 Bayer Corporation Method of treating otitis with ciprofloxacin-hydrocortisone suspension
DE19524691A1 (de) 1995-07-06 1997-01-09 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Innenohr und Labyrinth-Symptomen
KR0155950B1 (ko) 1995-08-16 1998-12-01 김광호 플라즈마 확산 제어 방법 및 그 장치
KR100508227B1 (ko) 1997-03-14 2006-03-23 센주 세이야꾸 가부시키가이샤 로테프레드놀에타보네이트수성현탁액
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
AR020661A1 (es) 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
JP2002525326A (ja) 1998-09-30 2002-08-13 アルコン ラボラトリーズ，インコーポレイテッド 眼、耳および鼻治療用の抗生物質組成物
AR020660A1 (es) 1998-09-30 2002-05-22 Alcon Lab Inc Composiciones antibioticas para el tratamiento de ojos, oidos y nariz
ATE252887T1 (de) * 1999-09-24 2003-11-15 Alcon Inc Topische suspensionsformulierungen enthaltend ciprofloxacin und dexamethason

Also Published As

Publication number Publication date
ATE252887T1 (de) 2003-11-15
JP2011032293A (ja) 2011-02-17
EP1214056B1 (en) 2003-10-29
EP1214056A1 (en) 2002-06-19
ZA200201904B (en) 2003-05-28
WO2001022936A8 (en) 2002-01-24
KR20020069508A (ko) 2002-09-04
US6284804B1 (en) 2001-09-04
SA00210418B1 (ar) 2006-04-22
HK1045653B (zh) 2004-01-30
CA2379605A1 (en) 2001-04-05
PL359623A1 (en) 2004-08-23
US20010034339A1 (en) 2001-10-25
AU776609B2 (en) 2004-09-16
TWI228423B (en) 2005-03-01
PT1214056E (pt) 2004-02-27
DE60006262T2 (de) 2004-05-13
AU7057000A (en) 2001-04-30
ES2207549T3 (es) 2004-06-01
BR0014203A (pt) 2002-05-21
KR100722502B1 (ko) 2007-05-28
AR025661A1 (es) 2002-12-11
PL201130B1 (pl) 2009-03-31
HK1045653A1 (en) 2002-12-06
WO2001022936A1 (en) 2001-04-05
DE60006262D1 (de) 2003-12-04
CN1376054A (zh) 2002-10-23
US6359016B2 (en) 2002-03-19
TR200200737T2 (tr) 2002-08-21
CA2379605C (en) 2007-06-26
JP2003510263A (ja) 2003-03-18
MXPA02003130A (es) 2004-04-21
CN1158994C (zh) 2004-07-28

Similar Documents

Publication Publication Date Title
DK1214056T3 (da) Topiske suspensionsformuleringer indeholdende ciprofloxacin og dexamethason
NO20016277D0 (no) Systemer og fremgangsmåter for aerolisering av farmasöytiske formuleringer
DK1353919T3 (da) Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
EE200200251A (et) Uued N-asabitsükloamiidi derivaadid ja nende kasutamine
DK1242095T3 (da) Antimikrobielle sammensætninger og fremgangsmåder til anvendelse deraf
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
NO20022334L (no) Ny sammensetning og anvendelse
NO20020180L (no) Nye kinuklidinderivater og medisinske sammensetninger inneholdende det samme
NO20013393D0 (no) Brönnsementeringsfremgangsmåter og sammensetninger
IS6411A (is) Kaspasa tálmar og notkun þeirra
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
DK1329456T3 (da) Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme
DE50013828D1 (de) Differenzverstärker
DK1173187T3 (da) Kombinationspræparater indeholdende morpholinylanthracycliner og platinderivater
DE60021170D1 (de) Verstärker
NO20034778L (no) Farmasöytiske sammensetninger for oral og topisk anvendelse
DE69911152D1 (de) Symmetrischer Verstärker
NO20004277D0 (no) Indolderivater og farmasøytiske sammensetninger omfattende det samme
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
NO20025968D0 (no) Pyridin-2-yl-aminoalkylkarbonylglycyl-<beta>-alanin og derivater derav
NO20005763D0 (no) DHEA-sammensetning og metode
DE60022934D1 (de) Verstärkerschaltungsanordnung
DK1066261T3 (da) Pyridinderivat og farmaceutisk præparat indeholdende samme
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos